Chemical and Pharmaceutical Bulletin · 1972 · 23 citations · 0 references
PharmacyMedicinal ChemistryPharmacologyBiochemical PharmacologyDrug DiscoveryMass Spectrometric AnalysisMass SpectrometryMetabolite IdentificationPeptide AnalysisSpectroscopic Analysis Of PharmaceuticalsStructural ElucidationErgot AlkaloidsFragmentation Pattern AnalysisMass Spectral FragmentationMass Spectral IdentificationMass Spectral InterpretationMass Spectrometric Drug AnalysisMass Spectrometric Structural ElucidationMass Spectrometric Structure Elucidation
Recently, Bellman has reported that mass spectrometry can be used to identify hallacinogenic drugs including lysergic acid diethylamide (LSD).4) Barber, et al. have investigated the mass spectrometry of some clavine and ergot-peptide alkaloids.5) But no mass spectral investigation of N6-substituted LSD has been described. The authors have been interested in the identification and the structual analysis of lysergic acid derivatives which are anticipated as natural products and transmitter sabstances in animal tissues and body fluids. In the present investigation the mass spectra of nine derivatives of lysergic acid are examined and the characteristic fragmentation pattens which might be important for structural analysis are discussed. The elemental composition of each fragment is confirmed by high resolution mass spectrometry.